| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/30/2013 | CN102329380B Method for coproduction of glucan, mannose and protein by utilizing industrial waste yeast |
| 01/30/2013 | CN102286084B Gingko biloba defensin, encoding gene and application thereof |
| 01/30/2013 | CN102268443B Application of corn WRKY gene in enhancing plant stress tolerance |
| 01/30/2013 | CN102127164B Method for extracting recombinant human serum albumin from rice seeds |
| 01/30/2013 | CN101979406B Multi-epitope protein for South Africa type II foot-and-mouth disease, and preparation method and application thereof |
| 01/30/2013 | CN101942013B HLA-DR9 restrictive regulatory T cell epitope of Hepatitis B virus core antigen and e antigen and application thereof |
| 01/30/2013 | CN101824079B Buckwheat Na+/H+ antiporter FtNHX and coding gene and application thereof |
| 01/30/2013 | CN101258166B Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 01/30/2013 | CN101027317B HPV vaccine comprising peptides from host cell proteins |
| 01/30/2013 | CN101001954B Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/29/2013 | US8362340 Maize variety hybrid X7H250 |
| 01/29/2013 | US8362335 Plants and seeds of corn variety CV704139 |
| 01/29/2013 | US8362334 Plants and seeds of corn variety CV806292 |
| 01/29/2013 | US8362333 Plants and seeds of corn variety CV699725 |
| 01/29/2013 | US8362325 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 01/29/2013 | US8362225 Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
| 01/29/2013 | US8362224 Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases |
| 01/29/2013 | US8362223 Hemopoietin receptor protein, NR10 |
| 01/29/2013 | US8362218 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| 01/29/2013 | US8362216 Method of detection using antibodies that specifically bind hedgehog-derived polypeptides |
| 01/29/2013 | US8362207 Multi-level specific targeting of cancer cells with IL-13 |
| 01/29/2013 | US8362206 Chimeric proteins and uses thereof |
| 01/29/2013 | US8362205 Delocalization molecules and use thereof |
| 01/29/2013 | US8362202 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
| 01/29/2013 | US8362201 Insecticidal compounds and methods for selection thereof |
| 01/29/2013 | US8362084 Histone deacetylases, and uses related thereto |
| 01/29/2013 | US8361981 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides |
| 01/29/2013 | US8361970 Growth factor binding molecules |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361966 Use of interleukin-11 as therapeutic agent for heart disease |
| 01/29/2013 | US8361965 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof |
| 01/29/2013 | US8361963 Uses of FGF21 polypeptides comprising two or more mutations |
| 01/29/2013 | US8361961 O-linked glycosylation of peptides |
| 01/29/2013 | US8361933 Polypeptide display libraries and methods of making and using thereof |
| 01/29/2013 | US8361795 Hepatopoietin and use thereof |
| 01/29/2013 | US8361774 Recombinant type II restriction endonuclease, NmeAIII, and a process for producing the same |
| 01/29/2013 | US8361773 Polynucleotides encoding polypeptides and host cells therefor |
| 01/29/2013 | US8361751 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 01/29/2013 | US8361750 rBSA from K. lactis expression, secretion and purification of recombinant bovine serum albumin (rBSA) from K. lactis and uses thereof |
| 01/29/2013 | US8361749 Process for preparing variant of Erysipelothrix rhusiopathiae surface protective antigen in E. coli |
| 01/29/2013 | US8361733 Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof |
| 01/29/2013 | US8361729 Detection of cells expressing T1R2 taste receptor |
| 01/29/2013 | US8361726 Method of detecting tumor-associated DNA in plasma or serum with a premalignant solid tumor |
| 01/29/2013 | US8361723 Keratin 8 mutations are risk factors for developing liver disease of multiple etiologies |
| 01/29/2013 | US8361711 Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances |
| 01/29/2013 | US8361485 Conditioned cell culture medium compositions and methods of use |
| 01/29/2013 | US8361479 Promiscuous PAP CD4 T cell epitopes |
| 01/29/2013 | US8361478 Recombinant viral-based malaria vaccines |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | US8361022 Apparatus for transdermal delivery of parathyroid hormone agents |
| 01/29/2013 | CA2610271C Autoactivated resistance protein |
| 01/29/2013 | CA2560487C Optimized expression of hpv 52 l1 in yeast |
| 01/29/2013 | CA2557295C Improved bacterial host cell for the direct expression of peptides |
| 01/29/2013 | CA2551039C Analogues of glp-1 |
| 01/29/2013 | CA2540884C C-terminally truncated interferon alpha variants |
| 01/29/2013 | CA2522081C Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/29/2013 | CA2501756C Isolated post-translationally modified proteins for monitoring and diagnosing muscle damage |
| 01/29/2013 | CA2482995C Low-cost production of peptides |
| 01/29/2013 | CA2477975C Novel vip3 toxins and methods of use |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2416137C Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 01/29/2013 | CA2349473C Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 01/29/2013 | CA2343929C Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/29/2013 | CA2342849C Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/29/2013 | CA2258485C Ribonuclease resistant rna preparation and utilization |
| 01/29/2013 | CA1341633C Interleukin-2 polypeptides |
| 01/24/2013 | WO2013013187A1 Apolipoprotein e polypeptides and their use |
| 01/24/2013 | WO2013013105A2 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| 01/24/2013 | WO2013013056A1 Method for treating amyloid disease |
| 01/24/2013 | WO2013012924A2 Engineered microbe-targeting molecules and uses thereof |
| 01/24/2013 | WO2013012922A1 Adenovirus e1a fragments for use in anti-cancer therapies |
| 01/24/2013 | WO2013012846A1 Process for preparing phosphorylated amino acids |
| 01/24/2013 | WO2013012824A2 Trichoplusia ni piggybac transposases with reduced integration activity |
| 01/24/2013 | WO2013012674A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | WO2013012446A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 01/24/2013 | WO2013012416A1 Process for preparing phosphorylated amino acids |
| 01/24/2013 | WO2013011426A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/24/2013 | WO2013011368A2 Novel il-17r-ecd mutants |
| 01/24/2013 | WO2013011347A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/24/2013 | WO2013011056A2 Pathology biomarker assay |
| 01/24/2013 | WO2013011011A2 Method of reversibly staining a target cell |
| 01/24/2013 | WO2013010998A2 Compositions and methods for immunomodulation |
| 01/24/2013 | WO2013010691A1 Plants resistant to insect pests |
| 01/24/2013 | WO2013010690A1 Down regulating gene expression in insect pests |
| 01/24/2013 | WO2013010537A1 Method of treating morphea |
| 01/24/2013 | WO2013010274A1 Methods for diagnosing and treating alzheimer's disease by administering an ανίίangiogenic agent |
| 01/24/2013 | WO2013010260A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | WO2013010254A1 Biomarkers for ankylosing spondylitis |
| 01/24/2013 | WO2013010225A1 Enzymes for degrading organophosphates |
| 01/24/2013 | WO2012166875A9 Modulating innate immune cell activity by lunasin and selected cytokines |
| 01/24/2013 | WO2012142113A3 Isopeptide bond formation in bacillus species and uses thereof |
| 01/24/2013 | WO2012131680A3 Compositions and methods for treating inflammation based on inhibiting cd151 activity |
| 01/24/2013 | WO2012104840A3 High molecular ordered fibrilar structures, method for their preparation and uses thereof |
| 01/24/2013 | WO2012063088A3 Collagen |
| 01/24/2013 | WO2007000584A8 Treatment of fungal and/or protist infections |
| 01/24/2013 | US20130025006 MODIFIED Cry1Ca INSECTICIAL Cry PROTEINS |